Home › Funds › Meiji Yasuda America Inc › GILD

Meiji Yasuda America Inc position in GILD

GILEAD SCIENCES INC · Health Care

Meiji Yasuda America Inc reported holding 53,386 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 1.04% of its reported portfolio and ranking #27 among its reported holdings. Meiji Yasuda America Inc has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)53.39K sh
Reported value held$7.96M
Portfolio Weight1.04%
First reportedQ4 2025
Last changeAdd
Updated2026-10-22

Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR

How Meiji Yasuda America Inc's GILD position evolved

Meiji Yasuda America Inc first disclosed a stake in GILD in Q4 2025 at 24,934 shares (US$3.1M). The position peaked in Q3 2026 at 53,386 shares, worth US$8.0M. Across 4 filings, Meiji Yasuda America Inc increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 53,386 shares valued at US$8.0M — an increase of 11,388 shares quarter over quarter.. Notable position changes include a 38% increase in Q2 2026 (shares rose 18% over the following quarter), a 27% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 24.93K $3.06M New
Q1 2026 30.45K $4.24M Add
Q2 2026 42.00K $5.31M Add
Q3 2026 53.39K $7.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Meiji Yasuda America Inc held GILD?

Meiji Yasuda America Inc has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Meiji Yasuda America Inc's current position in GILD?

As of Q3 2026, Meiji Yasuda America Inc holds 53.39K shares of GILD (GILEAD SCIENCES INC), valued at $7.96M, representing 1.04% of its reported portfolio and ranking #27.

Has Meiji Yasuda America Inc been buying or selling GILD?

In the latest 13F filing (Q3 2026), Meiji Yasuda America Inc increased its position in GILD. The position peaked in Q3 2026 at 53.39K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.